A39.52 Meningococcal myocarditis

Name of the Condition

• Meningococcal myocarditis

Summary

Meningococcal myocarditis is a rare complication of Neisseria meningitidis infection, involving inflammation of the heart muscle. It may occur as part of systemic meningococcal disease and can present with cardiac symptoms or findings. Prompt recognition and treatment are essential to manage cardiac involvement and prevent further complications.

Causes

Meningococcal myocarditis is caused by Neisseria meningitidis, a bacterium that spreads through respiratory droplets or direct contact with infected secretions. The infection may lead to myocarditis (inflammation of the heart muscle), typically as a result of bacteremia or septicemia.

Risk Factors

• Meningococcal infection (especially with certain serogroups).
• Underlying immunocompromised states or asplenia.
• Lack of vaccination against meningococcal disease.
• Close contact with an infected individual.
• Severe or prolonged meningococcal septicemia.

Symptoms

• Chest pain or discomfort.
• Shortness of breath.
• Palpitations or irregular heartbeat.
• Fatigue or weakness.
• Fever (if active infection persists).
• Signs of heart failure (e.g., swelling in legs, fluid retention).

Diagnosis

Diagnosis involves clinical evaluation and laboratory testing. Blood cultures may identify Neisseria meningitidis. Electrocardiograms (ECGs), echocardiograms, or cardiac MRI may detect myocardial inflammation or dysfunction. Elevated cardiac enzymes (e.g., troponin) can indicate heart muscle damage.

Treatment Options

Treatment focuses on eradicating the infection with appropriate antibiotics (e.g., ceftriaxone, penicillin) and managing cardiac symptoms. Supportive care may include medications for heart failure, anti-arrhythmics, or anti-inflammatory agents. In severe cases, intensive care monitoring or mechanical circulatory support may be necessary.

Prognosis and Follow-Up

Prognosis depends on the severity of myocardial involvement and timeliness of treatment. Early intervention improves outcomes, but severe cases may lead to heart failure or arrhythmias. Follow-up with cardiac monitoring (e.g., echocardiograms) is recommended to assess recovery and detect late complications.

Complications

• Heart failure (acute or chronic).
• Arrhythmias (e.g., ventricular tachycardia).
• Cardiogenic shock.
• Long-term cardiac dysfunction.

Lifestyle & Prevention

• Vaccination against meningococcal disease (e.g., MenACWY, MenB) is the primary preventive measure.
• Avoid close contact with infected individuals during outbreaks.
• Prompt treatment of meningococcal infection reduces the risk of myocarditis.

When to Seek Professional Help

Seek immediate medical attention if you experience chest pain, severe shortness of breath, palpitations, or signs of heart failure (e.g., leg swelling, fatigue) after a meningococcal infection or exposure.

Tips for Medical Coders

Code A39.52 is specific to meningococcal myocarditis. Document the clinical diagnosis, including evidence of myocardial inflammation (e.g., elevated troponin, ECG changes, or imaging findings) and its association with Neisseria meningitidis infection. Ensure differentiation from other cardiac complications of meningococcal disease (e.g., endocarditis, pericarditis) for accurate coding.